A Study to Evaluate the Effect of LCZ696 on Aortic Stiffness in Subjects With Hypertension
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 115 participants.
Also called NCT01870739
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 115 participants
- Sponsor
- Registry
-
NCT01870739 -
2012-005720-15
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Germany, Switzerland, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT01870739. Randomized; quadruple masking; primary purpose treatment. Start 2013-10 (registry gives no type); primary completion 2015-06 (actual). Results posted on 2016-09-01.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study to Evaluate the Effect of LCZ696 on Aortic Stiffness in Subjects With Hypertension
- Condition
- Hypertension
- Intervention (Drug)
- sacubitril/valsartan (LCZ696)
- Intervention (Drug)
- olmesartan
- Intervention (Other)
- placebo to sacubitril/valsartan (LCZ696)
- Intervention (Other)
- placebo to olmesartan
- Intervention (Drug)
- Amlodipine (Optional)
- Lead sponsor
- Novartis Pharmaceuticals
Record details
- Record id
cardio:ct-nct01870739- Content hash
9e2fb633767ccad211027e1a082be9161aa8e209f42ca007559b32f4c982bb76